Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

References

• Almirall DalyJValenzuelaMP2006The safety of phosphate bindersExpert Opin Drug Saf56758616907657
   PubMed Web of Science ®Google Scholar
• BlockGAHulbert-ShearonTELevinNW1998Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national studyAm J Kidney Dis31607179531176
   PubMed Web of Science ®Google Scholar
• BlockGARaggiPBellasiA2007Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patientsKidney Int714384117200680
   PubMed Web of Science ®Google Scholar
• CozzolinoMGalassiAPashoS2008Preventive measures and new pharmacological approaches of calcium and phosphate disordersContrib Nephrol161234918451682
   PubMed Web of Science ®Google Scholar
• De SantoNGFrangiosaAAnastasioP2006Sevelamer worsens metabolic acidosis in hemodialysis patientsJ Nephrol19S9S1081416736432
   PubMed Web of Science ®Google Scholar
• DelmezJBlockGRobertsonJ2007A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysisClin Nephrol683869118184521
   PubMed Web of Science ®Google Scholar
• DrüekeTB2007Lanthanum carbonate as a first-line phosphate binder: the “cons”Semin Dial203293217635823
   PubMed Web of Science ®Google Scholar
• DuggalAHanusMZhorovE2006Novel dosage forms and regimens for sevelamer-based phosphate bindersJ Ren Nutr162485216825030
   PubMed Web of Science ®Google Scholar
• EMEA2007Scientific discussion on Renagel Procedure EMEA/H/C000254/II/56, 1 June 2007
   Google Scholar
• GaneshSKStackAGLevinNW2001Association of elevated serum PO4, Ca × PO4 product, and paratyroid hormone with cardiac mortality risk in chronic hemodialysis patientsJ Am Soc Nephrol122131811562412
   PubMed Web of Science ®Google Scholar
• GiachelliCM2003Vascular calcification: in vitro evidence for the role of inorganic phosphateJ Am Soc Nephrol14S300412939385
   PubMed Web of Science ®Google Scholar
• HamerRAEl NahasM2006The burden of chronic kidney diseaseBMJ332563416528062
   PubMed Web of Science ®Google Scholar
• Kalantar-ZadehKMehrotraRFouqueD2004Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failureSemin Dial174556515660576
   PubMed Web of Science ®Google Scholar
• KawagishiTNishizawaYKonishiT1995High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremiaKidney Int4882067474670
   PubMed Web of Science ®Google Scholar
• KestenbaumBSampsonJNRudserKD2005Serum phosphate levels and mortality risk among people with chronic kidney diseaseJ Am Soc Nephrol16520815615819
   PubMed Web of Science ®Google Scholar
• KettelerMRixMFanS2008Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysisClin J Am Soc Nephrol doi 10.2215/CJN.05161107
   PubMed Web of Science ®Google Scholar
• KrautJA1995The role of metabolic acidosis in the pathogenesis of renal osteodystrophyAdv Ren Replace Ther240517614335
   PubMedGoogle Scholar
• LacourBLucasAAuchereD2005Chronic renal failure is associated with increase tissue deposition of lanthanum after 28-day oral administrationKidney Int6710626915698446
   PubMed Web of Science ®Google Scholar
• LacourBNikolovIGJokiN2007Lanthanum carbonate, body lanthanum accumulation and potential liver toxicityNephrol Dial Transplant2217889917405793
   PubMed Web of Science ®Google Scholar
• LiXYangHYGiachelliCM2006Role of sodium-dependent phosphate co-transporter, Pit-1, in vascular smooth cell calcificationCirc Res989051216527991
   PubMed Web of Science ®Google Scholar
• MadanPBhayanaSChandraP2008Lower gastrointestinal bleeding: association with sevelamer useWorld J Gastroenterol142615618442219
   PubMed Web of Science ®Google Scholar
• MathewSTustisonKSSugataniT2008The mechanism of phopshorus as a cardiovascular risk factor in CKDJASN doi:10.1681/ASN.20070707060
   Google Scholar
• McIntyreCW2007New developments in the management of hyperphosphatemia in chronic kidney diseaseSemin Dial203374117635825
   PubMed Web of Science ®Google Scholar
• QunibiWY2007Cardiovascular calcification in nondialyzed patients with chronic kidney diseaseSemin Dial20134817374087
   PubMed Web of Science ®Google Scholar
• QunibiWMoustafaMMuenzLR2008A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) StudyAm J Kidney Dis519526518423809
   PubMed Web of Science ®Google Scholar
• RussoDMirandaIRuoccoC2007The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamerKidney Int7212556117805238
   PubMed Web of Science ®Google Scholar
• SigristMKTaalMWBungayP2007Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney diseaseClin J Am Soc Nephrol21241817928470
   PubMed Web of Science ®Google Scholar
• St. PeterWLLiuJWeinhandlE2008A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the dialysis clinical outcomes revisited (DCOR) randomized trial using claims dataAm J Kidney Dis514455418295060
   PubMed Web of Science ®Google Scholar
• SukiWN2008Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trialJ Ren Nutr1891818089452
   PubMed Web of Science ®Google Scholar
• SzetoCCWongTYChowKM2003Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialys patients: a randomized placebo-control trialJ Am Soc Nephrol1421192612874466
   PubMed Web of Science ®Google Scholar
• ToussaintNDKerrPG2007Vascular calcification and arterial stiffness in chronic kidney disease: implications and managementNephrology12500917803475
   PubMed Web of Science ®Google Scholar
• WinkelmayerWCTonelliM2008Phosphate binder choice in dialysis patients: a call for evidence.based rather than marketing-based clinical practiceAm J Kidney Dis51362518295050
   PubMed Web of Science ®Google Scholar
• YoungEWAlbertJMSatayathumS2005Predictors and consequences of altered mineral metabolism: the dialysis outcomes and practice patterns studyKidney Int6711798715698460
   PubMed Web of Science ®Google Scholar
• YoungEW2007Mineral metabolism and mortality in patients with chronic kidney diseaseAdv Chronic Kidney Dis14132117200039
   PubMed Web of Science ®Google Scholar